RFK Jr. vs. Oz sets up clash on weight loss drug coverage
Two of President-elect Trump’s top health nominees are on a collision course as the incoming administration faces a crucial decision on coverage for groundbreaking anti-obesity drugs. Mehmet Oz, Trump’s pick to run the Centers for Medicare and Medicaid Services,
Elon Musk Admits To Using Weight Loss Medication Criticized By RFK Jr, Says He Prefers Mounjaro Over Miracle Drug Ozempic
“While no drug is without side effects, health problems associated with obesity almost certainly exceed the risks of GLP-1 agonists,” Musk said as early as Oct. 2023. GLP-1 agonists are a class of medications that can help manage Type 2 diabetes and obesity.
Should RFK Jr. be confirmed as HHS secretary, he will wield power over policy details that could shape the trajectory of U.S.
The Biden administration proposed expanding coverage of weight loss medication to Medicaid and Medicare recipients. RFK Jr.
Robert F. Kennedy Jr. has swept onto Capitol Hill. The anti-vaccine health guru from the famous political family is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback